123 related articles for article (PubMed ID: 261975)
1. Diabetic status in leprosy.
Nigam P; Dayal SG; Srivastava P; Joshi LD; Goyal BM; Dutt B; Gupta MC
Hansenol Int; 1979 Jun; 4(1):7-14. PubMed ID: 261975
[TBL] [Abstract][Full Text] [Related]
2. Histoid leprosy: a retrospective study of 40 cases from India.
Kaur I; Dogra S; De D; Saikia UN
Br J Dermatol; 2009 Feb; 160(2):305-10. PubMed ID: 19016704
[TBL] [Abstract][Full Text] [Related]
3. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
Fabian W; Majkowska L; Stefański A; Moleda P
Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
[TBL] [Abstract][Full Text] [Related]
4. Diabetic status of patients with leprosy in Kuwait.
Saraya MA; Al-Fadhli MA; Qasem JA
J Infect Public Health; 2012 Oct; 5(5):360-5. PubMed ID: 23164565
[TBL] [Abstract][Full Text] [Related]
5. Histopathological study of apparently normal skin of patients with leprosy.
El-Darouti MA; Hussein S; Marzouk SA; Nabil N; Hunter NS; Mahgoub D; El-Eishi NH; Abdel-Halim MR
Int J Dermatol; 2006 Mar; 45(3):292-6. PubMed ID: 16533232
[TBL] [Abstract][Full Text] [Related]
6. A study on the impact of FD-MDT on 200 leprosy patients.
Vara N; Marfatiya Y
Indian J Lepr; 2005; 77(3):217-27. PubMed ID: 16353520
[TBL] [Abstract][Full Text] [Related]
7. DNA damage studies in untreated and treated leprosy patients.
Gandhi G; Singh B
Mutagenesis; 2004 Nov; 19(6):483-8. PubMed ID: 15548761
[TBL] [Abstract][Full Text] [Related]
8. Antigens of Mycobacterium leprae in urine during treatment of patients with lepromatous leprosy.
Olcén P; Harboe M; Warndorff van Diepen T
Lepr Rev; 1986 Dec; 57(4):329-40. PubMed ID: 3540495
[No Abstract] [Full Text] [Related]
9. Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesion.
Majumder V; Saha B; Hajra SK; Biswas SK; Saha K
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):283-90. PubMed ID: 11221091
[TBL] [Abstract][Full Text] [Related]
10. Gender differences in epidemiological factors associated with treatment completion status of leprosy patients in the most hyperendemic district of Nepal.
Kumar RB; Singhasivanon P; Sherchand JB; Mahaisavariya P; Kaewkungwal J; Peerapakorn S; Mahotarn K
Southeast Asian J Trop Med Public Health; 2004 Jun; 35(2):334-9. PubMed ID: 15691132
[TBL] [Abstract][Full Text] [Related]
11. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
12. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
Mane I; Cartel JL; Grosset JH
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595
[TBL] [Abstract][Full Text] [Related]
13. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
[TBL] [Abstract][Full Text] [Related]
14. A study of cell mediated immunity in leprosy.
Dubey GK; Joglekar VK; Hardas UD; Chaubey BS
Lepr India; 1981 Apr; 53(2):197-203. PubMed ID: 7253571
[TBL] [Abstract][Full Text] [Related]
15. Transmission of leprosy within households.
Rao PS; Karat AB; Kaliaperumal VG; Karat S
Int J Lepr Other Mycobact Dis; 1975; 43(1):45-54. PubMed ID: 1171831
[TBL] [Abstract][Full Text] [Related]
16. Orofacial lesions in treated southeast Brazilian leprosy patients: a cross-sectional study.
Martins MD; Russo MP; Lemos JB; Fernandes KP; Bussadori SK; Corrêa CT; Martins MA
Oral Dis; 2007 May; 13(3):270-3. PubMed ID: 17448207
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to a synthetic analog of phenolic glycolipid-I of Mycobacterium leprae in healthy household contacts of patients with leprosy.
Menzel S; Harboe M; Bergsvik H; Brennan PJ
Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):617-25. PubMed ID: 3323365
[TBL] [Abstract][Full Text] [Related]
18. Malaria, leprosy and dapsone.
Saha K; Kapoor L; Arora VM; Chattopadhya D
Southeast Asian J Trop Med Public Health; 2003 Sep; 34(3):501-4. PubMed ID: 15115119
[TBL] [Abstract][Full Text] [Related]
19. Immune status of subsided cases of tuberculoid (TT) and borderline tuberculoid (BT) leprosy.
Mackay IG; Sengupta U; Ghei SK; Sinha S; Ramu G
Lepr India; 1982 Oct; 54(4):653-63. PubMed ID: 6763967
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy.
Narang T; Kaur I; Kumar B; Radotra BD; Dogra S
Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):105-14. PubMed ID: 16830653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
